Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matzku

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Cancer Treatment Reviews|September 1, 1990
Pitfalls in the clinical application of monoclonal antibodies in malignant melanoma: modulation by and impaired accessibility of antigens to monoclonal antibodiesW Tilgen, S Matzku
Drugs of Today (Barcelona, Spain : 1998)|July 9, 2003
Vaccination: a future modality of cancer therapyM Zoller, S Matzku
Journal of the National Cancer Institute|October 1, 1980
Specific cytotoxicity in vitro by T-cell-enriched lymphocyte subpopulations from rats bearing chemically induced but not spontaneous tumorsM Zöller, S Matzku
Immunobiology|October 26, 1999
Cancer therapy: new concepts on active immunizationM Zöller, S Matzku
Drugs & Aging|October 16, 2001
Specific immunotherapy of cancer in elderly patientsS Matzku, M Zöller
Journal of Immunological Methods|January 1, 1976
Antigen and antibody purification by immunoadsorption: elimination of non-biospecifically bound proteinsM Zoller, S Matzku
Immunochemistry|May 1, 1977
Iodination of immunoadsorbed antibodies: chloramine T vs lactoperoxidaseS Matzku, M Zöller
Immunobiology|August 1, 1983
Rat natural killer (NK) cells are not bone marrow dependentM Zöller, S Matzku
Immunobiology|February 1, 1983
Natural killer (NK) cells in the rat: "heterogeneity" as reflection of the activation statusM Zöller, S Matzku
Chirurgisches Forum Fur Experimentelle Und Klinische Forschung|January 1, 1978
[Leukocyte migration test and determination of carcinoembryonic antigens in the postoperative follow-up care of colon and rectum carcinoma]U Schulz, M Zoeller, S Matzku
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Cancer Treatment Reviews|September 1, 1990
Pitfalls in the clinical application of monoclonal antibodies in malignant melanoma: modulation by and impaired accessibility of antigens to monoclonal antibodiesW Tilgen, S Matzku
Drugs of Today (Barcelona, Spain : 1998)|July 9, 2003
Vaccination: a future modality of cancer therapyM Zoller, S Matzku
Journal of the National Cancer Institute|October 1, 1980
Specific cytotoxicity in vitro by T-cell-enriched lymphocyte subpopulations from rats bearing chemically induced but not spontaneous tumorsM Zöller, S Matzku
Immunobiology|October 26, 1999
Cancer therapy: new concepts on active immunizationM Zöller, S Matzku
Drugs & Aging|October 16, 2001
Specific immunotherapy of cancer in elderly patientsS Matzku, M Zöller
Journal of Immunological Methods|January 1, 1976
Antigen and antibody purification by immunoadsorption: elimination of non-biospecifically bound proteinsM Zoller, S Matzku
Immunochemistry|May 1, 1977
Iodination of immunoadsorbed antibodies: chloramine T vs lactoperoxidaseS Matzku, M Zöller
Immunobiology|August 1, 1983
Rat natural killer (NK) cells are not bone marrow dependentM Zöller, S Matzku
Immunobiology|February 1, 1983
Natural killer (NK) cells in the rat: "heterogeneity" as reflection of the activation statusM Zöller, S Matzku
Chirurgisches Forum Fur Experimentelle Und Klinische Forschung|January 1, 1978
[Leukocyte migration test and determination of carcinoembryonic antigens in the postoperative follow-up care of colon and rectum carcinoma]U Schulz, M Zoeller, S Matzku
Pageof 10